Why stopping Mounjaro abruptly triggers rapid weight regain in patients

Mounjaro, a weekly injection used for weight loss and long-term metabolic health, is not meant for short-term use. Patients who stop taking it often face rapid weight regain and increased appetite. The drug's cost has also risen sharply, adding pressure to those considering their options.

Mounjaro was launched in late 2023 as a long-term treatment rather than a quick fix. Its price, however, has become a growing concern. In the UK, the highest dose now costs around £300 per month when sourced privately. Globally, prices are under pressure due to competition and patent rules, with declines of over 20% expected for similar drugs like semaglutide (Wegovy) by 2026. Yet, Eli Lilly reported strong revenue growth in the last quarter, suggesting demand remains high.

Stopping Mounjaro abruptly can trigger a sudden surge in appetite and weight gain. The amount regained often matches the initial weight lost. To reduce these effects, doctors recommend tapering the dose over 4 to 8 weeks instead of quitting suddenly. If cost is an issue, lowering to the highest affordable dose may be better than stopping entirely.

For those who do stop, maintaining a healthy diet and regular exercise becomes even more critical. Some patients switch to alternatives like semaglutide, though results and side effects may differ. Mounjaro's role shifts over time—initially suppressing appetite, then helping prevent weight regain as the body adjusts.

The decision to stop Mounjaro requires careful planning due to the risks of weight regain and appetite changes. Gradual reduction and lifestyle adjustments can help ease the transition. With rising costs and limited alternatives, patients must weigh their options based on affordability and long-term health goals.